Iron deprivation inhibits cyclin-dependent kinase activity and decreases cyclin D/CDK4 protein levels in asynchronous MDA-MB-453 human breast cancer cells.

被引：0
|
作者：
Kulp, KS
Green, SL
Vulliet, PR
机构：
[1] UNIV CALIF DAVIS,SCH VET MED,DEPT MOL BIOSCI,DAVIS,CA 95616
[2] STANFORD UNIV,DEPT COMPARAT MED,PALO ALTO,CA 94305
来源：
MOLECULAR BIOLOGY OF THE CELL | 1996年 / 7卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：2135 / 2135
页数：1
相关论文
共 50 条
  • [21] Eicosapentaenoic acid decreases protein kinase a activity and β1 integrin expression in MDA-MB-231 human breast cancer cells.
    German, NS
    Johanning, GL
    FASEB JOURNAL, 1998, 12 (05): : A657 - A657
  • [22] The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is an antiestrogen-regulated inhibitor of Cdk4 in human breast cancer cells
    Skildum, AJ
    Mukherjee, S
    Conrad, SE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (07) : 5145 - 5152
  • [23] The impact of cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) on the incidence of alopecia in patients with metastatic breast cancer (BC)
    Eiger, Daniel
    Wagner, Marcio
    Ponde, Noam F.
    Nogueira, Melanie S.
    Buisseret, Laurence
    de Azambuja, Evandro
    ACTA ONCOLOGICA, 2020, 59 (06) : 723 - 725
  • [24] Bone morphogenetic protein-2 blocks MDA MB 231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastoma protein phosphorylation
    Ghosh-Choudhury, N
    Woodruff, K
    Qi, WB
    Celeste, A
    Abboud, SL
    Choudhury, GG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (03) : 705 - 711
  • [25] DIFFERENTIAL REQUIREMENTS FOR INTERLEUKIN-2 DISTINGUISH THE EXPRESSION AND ACTIVITY OF THE CYCLIN-DEPENDENT KINASES CDK4 AND CDK2 IN HUMAN T-CELLS
    MODIANO, JF
    DOMENICO, J
    SZEPESI, A
    LUCAS, JJ
    GELFAND, EW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (52) : 32972 - 32978
  • [26] CDK4 Phosphorylation Regulates Smad3 Activity in Cyclin D1 Overexpressing Breast Cancer Cells
    Zelivianski, S.
    Cooley, A. E.
    Jeruss, J. S.
    CANCER RESEARCH, 2009, 69 (24) : 641S - 642S
  • [27] Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients
    Zhang, T
    Nanney, LB
    Luongo, C
    Lamps, L
    Heppner, KJ
    DuBois, RN
    CANCER RESEARCH, 1997, 57 (01) : 169 - 175
  • [28] Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
    Ogata, Ryohei
    Kishino, Emi
    Saitoh, Wataru
    Koike, Yoshikazu
    Kurebayashi, Junichi
    BREAST CANCER, 2021, 28 (01) : 206 - 215
  • [29] Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells
    Ryohei Ogata
    Emi Kishino
    Wataru Saitoh
    Yoshikazu Koike
    Junichi Kurebayashi
    Breast Cancer, 2021, 28 (1) : 206 - 215
  • [30] Real world quality of life (QoL) in breast cancer (BC) patients treated with cyclin-dependent kinase 4/6 inhibitors (CDK4/6i)
    Tavara, B. I.
    Garrido, M. L.
    Lopez, L.
    Lopez Flores, M.
    Castanon, C.
    Abella Alvarez, S.
    Medina Valdivieso, S.
    Rodriguez Sanchez, A.
    Garcia Palomo-Perez, A.
    Lopez, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S361 - S361
12345